Abstract
PURPOSE: Adenocarcinoma of the appendix is a rare neoplasm, and controversies persist regarding management. The purpose of this study was to identify prognostic factors and define management strategies for patients with adenocarcinoma of the appendix. METHODS: A retrospective case series was conducted at three medical school teaching hospitals over a 20-year period from 1972 to 1992. Overall survival was determined by the actuarial life table method. Comparisons of prognostic factors were made using exact nonparametric log-rank tests. RESULTS: Thirteen patients were diagnosed during the study period. Median age was 62 years. There were five males and eight females. The disease swas not suspected in any patient preoperatively. Seventyseven percent of patients had metastatic disease at presentation. Second primary malignancies were found in 15 percent of patients. Thirty-eight percent of female patients had synchronous ovarian lesions. Median survival was 22 months, with an estimated five-year survival of 43 percent (95 percent confidence interval, 22–84 percent). Patients with colonic histology had significantly worse survival than patients with mucinous histology ( tP=0.0093). Patients with carcinomatosis had a significantly worse survival than noncarcinomatosis patients ( tP=0.0078). Patients who underwent right hemicolectomy had a better prognosis for survival than appendectomy patients, but the difference was not statistically significant. CONCLUSIONS: Carcinoma of the appendix is very difficult to diagnose preoperatively, and most patients are not identified until disease is advanced. Good prognostic factors include mucinous histology and the absence of carcinomatosis. Right hemicolectomy appears to be a reasonable option, although its superiority to appendectomy alone has not been definitively proven. High frequency of ovarian metastases in women suggests a role for bilateral oophorectomy. In addition, a complete work-up of the patient for a synchronous malignancy, especially in the gastrointestinal tract, should be considered.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lyss AP. Appendiceal malignancies. Semin Oncol 1988;15:129–37.
Rutledge RH, Alexander JW. Primary appendiceal malignancies. Surgery 1992;111:244–50.
Gamble HA. Adenocarcinoma of the appendix: an unusual case and review. Dis Colon Rectum 1976;19:621–5.
Berger A. Ein fall von krebs des Wurmfortsatzes. Klin Wochenschr 1882;19:616–8.
Nitecki SS, Wolff BG, Schlinkert R, Sarr MG. The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg 1994;219:51–7.
Mehta C, Patel N. STATXACT: statistical software for exact nonparametric inference. Version 2. Cytel Software Corp., Cambridge, MA, 1991.
Schlatter MG, McKone TK, Scholten DJ, Bonnell BW, DeKryger LL. Primary appendiceal adenocarcinoma. Am Surg 1987;53:434–7.
Chen KT, Spaulding RW. Appendiceal carcinoma masquerading as primary bladder carcinoma. J Urol 1991;145:821–2.
Baskin LS, Stoller ML. Unusual appendiceal pathology presenting as urologic disease. Urology 1991;38:432–6.
Scott MJ. Primary adenocarcinoma of the vermiform appendix masquerading as Crohn's disease. Eur J Surg 1990;157:153–4.
Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Pseudomyxoma peritonei of appendiceal origin: the Memorial Sloan-Kettering Cancer Center experience. Cancer 1992;70:396–401.
Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei: a clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991;15:415–29.
Didolkar MS, Fanous N. Adenocarcinoma of the appendix: a clinicopathologic study. Dis Colon Rectum 1977;20:130–4.
Brown HW, Husni EA. Ruptured adenocarcinoma of the appendix: review of the literature and case presentation. Surgery 1957;42:953–8.
Cerame MA. A 25 year review of adenocarcinoma of the appendix: a frequently perforating carcinoma. Dis Colon Rectum 1988;31:145–50.
Gough DB, Donohue JH, Schutt AJ,et al. Pseudomyxoma peritonei: long-term patient survival with an aggressive regional approach. Ann Surg 1994;219:112–9.
Paulman P, Klug R. Pseudomyxoma peritonei. Am Fam Physician 1986;33:173–4.
Sugarbaker PH, Kern K, Lack E. Malignant pseudomyxoma peritonei of colonic origin: natural history and presentation of a curative approach to treatment. Dis Colon Rectum 1987;30:772–9.
Novell R, Lewis A. Role of surgery in the treatment of pseudomyxoma peritonei. J R Coll Surg Edinb 1990;35:21–4.
Mann WJ Jr, Wagner J, Chumas J, Chalas E. The management of pseudomyxoma peritonei. Cancer 1990;66:1636–40.
Sugarbaker PH, Landy D, Jaffe G, Pascal R. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. Cancer 1990;65:1495–501.
Fernandez RN, Daly JM. Pseudomyxoma peritonei. Arch Surg 1980;115:409–14.
Seddon JA. Adenocarcinoma of the appendix associated with multiple adenocarcinomas of the colon. Am Surg 1965;31:180–3.
Conte CC, Petrelli NJ, Stulc J, Herrera L, Mittelman A. Adenocarcinoma of the appendix. Surg Gynecol Obstet 1988;166:451–3.
Lesnick G, Miller D. Adenocarcinoma of the appendix. Cancer 1949;2:18–24.
Chang P, Attiyeh FF. Adenocarcinoma of the appendix. Dis Colon Rectum 1981;24:176–80.
Author information
Authors and Affiliations
Additional information
This work supported in part by American Cancer Society Career Development Award 93–283.
Read at the Annual Meeting of the Virginia Surgical Society, Homestead, Virginia, May 1 to 2, 1994.
About this article
Cite this article
Cortina, R., McCormick, J., Kolm, P. et al. Management and prognosis of adenocarcinoma of the appendix. Dis Colon Rectum 38, 848–852 (1995). https://doi.org/10.1007/BF02049842
Issue Date:
DOI: https://doi.org/10.1007/BF02049842